Background: Cerebrospinal fluid (CSF) levels of inflammatory biomarkers have been suggested to predict multiple sclerosis development after clinically isolated syndromes, but there is a need for studies looking at the long-term prognosis. Aim: To assess the predictive ability of CSF biomarkers of inflammation and tissue-damage with regard to development of clinically definite multiple sclerosis (CDMS) and long-term disability. Methods: 86 patients with acute optic neuritis (ON) as a first demyelinating event seen in our clinic between 1993 and 2002 were included retrospectively. Patients had undergone MRI and a lumbar puncture b 3 months from onset; CSF was stored at −80°C. Established MS-risk parameters (MRI, CSF leukocyte count, IgG-index and oligoclonal bands) were registered and CSF levels of chitinase-3-like-1 (CHI3L1), osteopontin, neurofilament light chain (NFL), myelin basic protein, CCL2, CXCL10, CXCL13 and matrix metalloproteinase-9 were measured by ELISA. Patients were followed up after a median time of 13.6 (range: 9.6-19.4) years. 81.4% were examined by the corresponding author including an EDSS and multiple sclerosis functional composite (MSFC) evaluation. 18.6% were interviewed by phone, incl. an EDSS-questionnaire. Time to CDMS was confirmed by collection of original charts from treating hospitals. Cox regression was used for time to CDMS, multiple regression for multiple sclerosis severity score (MSSS) and MSFC. Results: 46 of 86 (53.5%) developed CDMS between ON and followup. Of the established MS-risk parameters, MRI (p = 0.0008) and leukocyte count (p = 0.036) combined predicted MS development best. These two were then tested in a second model with the other CSF biomarkers, where MRI (p = 0.0001) and CHI3L1 (p = 0.017) combined predicted MS development best. NFL predicted long-term disability as assessed by the MSSS (p = 0.0135), nine-hole peg test (p = 0.0137) and visual acuity (p = 0.0005). CHI3L1 predicted longterm cognitive impairment as assessed by the paced auditory serial addition test (p = 0.0142). Conclusions: NFL and CHI3L1 were significant predictors of long-term physical and cognitive disability. We have previously suggested these to be markers of tissue damage-related inflammation in ON, supporting these findings. Furthermore, CHI3L1 appeared to predict CDMS better than the CSF parameters commonly used today. Thus, the two hold potential as clinically valuable biomarkers of future MS disease and disability after a first demyelinating event.
The dogma of central nervous system (CNS) immune-privilege began to break down with the realization that immune cell infiltration into the CNS may be more common than previously believed. In addition to brain injury and neurological diseases, there is now growing evidence that neural-immune crosstalk may even occur in non-disease conditions. The dynamical behavior of immune cells in intact/injured CNS has not been well characterized with in-vivo imaging techniques, because it is difficult to perform long-term visualization of cell motility in the live tissue with minimal invasion. Non-invasive monitoring of immune cells in the CNS may lead to a greater understanding of the mechanisms of the immune systems in CNS homeostasis and progression of diseases. Since the application of magnetic resonance imaging (MRI), the studies using MRI in immunology have increased dramatically. When carried out at high resolution, MRI can be used to study the mechanism underlying cell infiltration and migration in the healthy and inflamed CNS. Here, we describe highly sensitive in-vivo MRI techniques for sequential monitoring of cell migration in the CNS at the single-cell level. We demonstrate that MRI with in-situ labeling with superparamagnetic particles of iron oxide (SPIO) can be used to successfully monitor the transmigration of peripheral phagocytes into healthy and inflamed brains. We also show dynamic cell migration in live animal brains with time-lapse MRI videos. Time-lapse MRI was used to visualize and track both stationary cells and cells with low motility in a control mouse brain. In the study with ischemia model, many SPIO-labeled macrophages were detected around the infarction. Some labeled cells were also found in the healthy area similar to what we have seen in the control. The cell migration velocity markedly slowed down by the ischemic area. Although most labeled cells in the healthy area disappeared by 1 week, cells aggregated at the edges of the infarction remained for a long period. Those cells disappeared from the brain, coincident with the disappearing of the T2-weighted highintensity region. Our novel MRI techniques as a tool to monitor dynamic behaviors of cell migration may reveal critical insights into cell behaviors that are not obtained by optical microscopy. Our technique could contribute to understand the neuro-immune crosstalk and to reveal the mechanisms of immune cell dynamics in the normal CNS as well as injuries, inflammation and diseases. doi:10.1016/j.jneuroim.2014.08.064
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